Brandon Nuechterlein, PA-C, MPAS

Sr. Instructor, Pediatrics-Heme/Onc and Bone Marrow Transplantation


FacultyPhoto
Graduate School
  • PA, University of Colorado Denver (2009)
Undergraduate School
  • BS, University of Colorado - Denver (CO) (2006)
Languages
English
Department
Pediatrics-Heme/Onc and Bone Marrow Transplantation

Professional Titles

  • Senior Instructor of Pediatrics

Recognitions

  • Senior Instructor with Distinction, Children's Hospital Colorado (2015)
  • APP SIG Lifetime Achievement Award, ASTCT & CIBMTR (2023)
    This award recognizes a SIG member for their outstanding work and dedication to APP practice in hematopoietic cell transplantation (HCT) and cellular therapy, through consistent, high-quality contributions to the field through publications, presentations, mentorship, and leadership.
  • Senior Expert, Clinical Practice Development, University of Colorado School of Medicine, Department of Pediatrics (2023)
  • Outstanding Service Adjunct Award, Childrens Hospital Colorado (2023)
  • Senior Expert of Research, University of Colorado School of Medicine, Department of Pediatrics (2024)

Publications

  • Koo J, Silverman S, Nuechterlein B, Keating AK, Verneris MR, Foreman NK, Mulcahy Levy JM. Safety and feasibility of outpatient autologous stem cell transplantation in pediatric patients with primary central nervous system tumors. Bone Marrow Transplant. 2019 Oct;54(10):1605-1613. PubMed PMID: 30783209
  • Phelan R, Eissa H, Becktell K, Bhatt N, Kudek M, Nuechterlein B, Pommert L, Tanaka R, Baker KS. Upfront Therapies and Downstream Effects: Navigating Late Effects in Childhood Cancer Survivors in the Current Era. Curr Oncol Rep. 2019 Nov 25;21(12):104. PubMed PMID: 31768799
  • BrandonNuechterleinMPAS1HeshamEissaMD2Michael R.VernerisMD3Christopher M.McKinneyMD4MelissaCroskell5 https://doi.org/10.1016/j.bbmt.2019.12.175 What Is the Optimal Post-Transplant Cardiac Screening for Transplant Recipients with a Non-Malignant Disease? Biology of Blood and Marrow Transplantation Volume 26, Issue 3, Supplement, March 2020, Page S351 538
  • Nuechterlein B. Against all odds. Lancet Haematol. 2023 Sep;10(9):e709. PubMed PMID: 37652599
  • Duncan CN, Brazauskas R, Huang J, Shaw BE, Majhail NS, Savani BN, Flowers MED, Battiwalla M, Beebe K, Dietz AC, Dvorak CC, Giller R, Jacobsohn DA, Kletzel M, Martin PL, Nemecek ER, Nuechterlein B, Talano JA, Pulsipher MA, Baker KS. Late cardiovascular morbidity and mortality following pediatric allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2018 Oct;53(10):1278-1287. PubMed PMID: 29581480
  • Vasu S, Holtan SG, Shimamura A, Burnworth T, Whisenton S, Adams S, Nuechterlein B, Mortier N, Foster J, DiFronzo N, Horowitz M, Rizzo D, Foley A. Bringing Patient and Caregivers Voices to the Clinical Trial Chorus: A Report From the BMT CTN Patient and Caregiver Advocacy Task Force. Transplant Cell Ther. 2023 Jan;29(1):5-9. PubMed PMID: 36283516
  • Unrelated Cord Blood Transplant (UCBt) Is Associated Low Rates of Longterm, Persistent Graft Versus Host Disease (GVHD) 1. J.A. Craddock, A. Alsultan, R.R. Quinones, A. Keating, E. Hild, N. Benkhalil, D. Law, A. Peltz, B. Nuechterlein, K. Drake, S. Smolik, R.H. Giller, Biology of Blood and Marrow Transplantation, Volume 18, Issue 2, S230 - S231
  • 2. Brandon Nuechterlein, Angela Peltz, Kelly Drake, Michele Finnerty, Amy Keating, John Craddock, Suzzanne Smolik, Ralph Quinones, Roger Giller, Optimizing Cyclosporine Dosing Regimen to Achieve Therapeutic Levels at the Time of Allogeneic Bone Marrow Transplantation: A Pediatric Quality Improvement Intervention, Biology of Blood and Marrow Transplantation, Volume 19, Issue 2, Supplement, 2013, Page S254, ISSN 1083-8791,
  • 3. Holly Pacenta, Rebecca Coughlin, Shelby Winzent, Joanne M. Hilden, Dianne Thornhill, Brian R. Branchford, Kelly Maloney, Nuechterlein Brandon, Amy Keating, Taizo Allen Nakano, Roger Giller, Christopher Michael McKinney, Optimizing Iron Overload Screening in a Pediatric Center for Cancer and Blood Disorders, Blood, Volume 130, Supplement 1, 2017, Page 2099,
  • 4. Brandon Nuechterlein, Hesham Eissa, Michael R. Verneris, Christopher M. McKinney, Melissa Croskell, What Is the Optimal Post-Transplant Cardiac Screening for Transplant Recipients with a Non-Malignant Disease?, Biology of Blood and Marrow Transplantation, Volume 26, Issue 3, Supplement, 2020,
  • 9. Christine N. Duncan, Nan Chen, Wendy B. London, Samantha Kay-Green, Lynnette Anderson, Ibrahim Ahmed, Jeffery J. Auletta, Barbara Bambach, Kristen L. Beebe, Sonali Chaudhury, James A Connelly, Blachy J Davila, Christopher C. Dvorak, W Scott Goebel, Rabi Hanna, Michelle Hudspeth, Jeffrey S. Huo, Neena Kapoor, Kimberly A. Kasow, Nahal Lalefar, Lyndsay Molinari, Eneida R. Nemecek, Brandon Nuechterlein, Benjamin Oshrine, Muna Qayed, Mark Vander Lugt, Bronwen E. Shaw, Mike A. Pulsipher, K. Scott Baker, Skeletal Biology and Late Effects Following Allogeneic Transplantation for Pediatric Hematologic Malignancy: A Ptctc and CIBMTR Multicenter Study 2022
  • 10. Maria A Pereda, Brandon Nuechterlein, Kristen Miller, Amy Keating, 131 - Comparison of Cyclophosphamide Vs Melphalan Combined with TBI for Pediatric ALL: A Single Center Experience, Transplantation and Cellular Therapy, Volume 29, Issue 2, Supplement, 2023, Page S105,
  • PMID: 37652599

Practice Locations

Children's Hospital Colorado Anschutz Medical Campus
13123 East 16th Ave
Aurora, CO 80045
720-777-1234

Hospital Affiliation
  • Children's Hospital Colorado

Specialty Information

Specialties
  • Pediatric Hematology / Oncology (2009)
  • Certified Physician Assistant, Certificate (0001)
Conditions & Treatments
  • Blood / Lymphatic System - Blood Disorders
  • Cancers - Pediatric Cancer
  • Blood / Lymphatic System
  • Cancers
  • Immune System - Immunodeficiency
  • Immune System
  • Genetic Conditions and Testing
  • Cancers - Blood and Marrow Transplant
Clinical Interests
I have a particular interest in advancing our therapeutic approaches to increase cure rates while minimizing late effects.

Care Philosophy
I had a bone marrow transplant at 15 for leukemia, and have been driven to pay it forward ever sense. Having, personally experienced cancer as well as bone marrow transplant has given me a unique perspective-- which many patients and families have found invaluable.

Personal Interests
I enjoy cycling, dirt biking, wake boarding, snowboarding and world traveling

Volunteer Activities
Courage Classic Team: Wheels of Justice and Relay for Life